Avatar

About Kim Rockley

Kim holds a PhD in Pharmacy from Durham University where she studied anthracycline-induced cardiotoxicity and its mitigation in vitro. Before this, Kim gained with a BSc in Biomedical Science and a Master’s degree in Cancer Pharmacology from the University of Bradford, graduating with distinction. She also has experience as a Clinical Trial Coordinator at the Haematology and Oncology Centre, University Hospitals Bristol NHS foundation Trust. Kim is a creative research scientist who enjoys the busy and dynamic environment of ApconiX.

Innovative Models for In Vitro Detection of Seizure

ApconiX is delighted that Dr Kim Rockley's article ‘ Innovative models for in vitro detection of seizure‘ has now been accepted for publication in Toxicology Research. The article highlights how new technologies such as microelectrode array and ion channel screening offer the opportunity to screen for seizure liability in vitro, avoiding costly failures in preclinical [...]

By |2019-11-20T15:45:04+00:00November 20th, 2019|Ion Channels, Publications|Comments Off on Innovative Models for In Vitro Detection of Seizure

ApconiX Conduct Pilot Study with Axion Biosystems

We were thrilled to welcome Jayne Ingram from Axion Biosystems into the ApconiX laboratory to conduct a pilot study using their Maestro Pro multielectrode array (MEA) system and Ncardia iPSC-derived neuronal cells.  The cells were cultured for three weeks before Jayne arrived to allow the formation of neuronal networks, which would allow us to assess [...]

By |2019-10-10T10:10:14+01:00October 10th, 2019|Ion Channels, Toxicology|Comments Off on ApconiX Conduct Pilot Study with Axion Biosystems